• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDC

MEDLAB CLINICAL LIMITED - Corporate Spotlight

0.00% ! $6.60
Currently unlisted.
Healthcare Biotechnology
Add to My Watchlist

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals with the objective of empowering patients with chronic diseases and mental health conditions and enhancing their lives. Its drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress. It also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. It is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

ASX Market Close: Fading miners drag bourse as iron ore price slumps | July 25

Good afternoon and welcome to Market Close @ I’m Isaac McIntyre. The ASX has closed down today, losing -0.49% in a dour end to what had been a relatively strong Week 30; up to this arvo’s trade, at least.Listen to the HotCopper podcast for in-depth discussions and ...
Astute delivers high-grade lithium hits at Red Mountain Astute Metals NL (ASX: ASE) has chalked up a strong close to its latest diamond drilling program, reporting the final batch of assay results from its wholly-owned Red Mountain Lithium Project in Nevada.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headli...
What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA The stock market is currently taking no prisoners. Megatrends such as AI and high-tech have enabled investors to reap substantial returns over the past two years. But for the past three months, defence and armament stocks have been performing a wild dance on the trading floor. This article is dis...
Most investors will get this earnings season wrong. Will you? ASX reporting season is here, and once again, most investors are going to get it wrong. Not because they’re not smart. But because they’re playing the wrong game.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from...
Rokeby, BHM, more: The 10 hot stocks HotCopper users watchlisted in Week 30 Every week, hundreds of companies go through the ups and downs of the ASX trading rollercoaster, with fortunes made and equity lost each time the bourse opens @ which is why keeping an eye on the hot stocks is so key.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.